Sterne Kessler Goldstein Fox

Media + Events

Diagnostic Testing in the Wake of Bilski v. Kappos

07.02.10 Michelle K. Holoubek and Eric K. Steffe, IPWatchdog.com

It has long been anticipated that the Bilski v. Kappos decision, though based on business method claims, would have implications that reached far beyond the business method world. Indeed, Justice Kennedy acknowledged that the M-or-T test would create uncertainty for new technologies of the Information Age, including, among other types of technologies, diagnostic medical testing techniques. (Bilski, Slip Op., p. 9.) The removal of the machine-or-transformation test as the sole test is good news for the biotech industry, particularly in the field of personalized medicine. Read the full article here.

Related Industries

Related Services

Related People

(1) Recent Headlines

Monica Riva Talley Joins Sterne, Kessler, Goldstein & Fox

Monica Riva Talley Joins Sterne, Kessler, Goldstein & Fox

09.08.10 Sterne, Kessler, Goldstein & Fox P.L.L.C.

Today we announced the expansion of our Trademark Practice with the addition of Monica Riva Talley, a veteran trademark attorney and law firm partner with more than 14 years of experience.
SKGF Named Finalist for Digital PR Award for The Reexamination Center

SKGF Named Finalist for Digital PR Award for The Reexamination Center

08.13.10 Sterne, Kessler, Goldstein & Fox P.L.L.C.

Sterne, Kessler, Goldstein & Fox has been named a finalist in PR News’ Digital PR Awards program in the Microsite/Custom Site category for The Reexamination Center, the first comprehensive website providing news, events, education, and analysis on all aspects of patent reexaminations.

New U.S. Biosimilar Act has Important Implications for Patent Licensing

New U.S. Biosimilar Act has Important Implications for Patent Licensing

08.04.10 Timothy J. Shea & Christine F. Norris, Sterne, Kessler, Goldstein & Fox P.L.L.C.

Timothy Shea and Christine Norris discuss the ramifications for patent licensing created by the passage of The Biologics Price Competition and Innovation Act, signed into law in March 2010.

Post-Grant Review: How Will It Affect Your (Client's) Business?

Post-Grant Review: How Will It Affect Your (Client's) Business?

08.02.10 Eldora L. Ellison and Byron L. Pickard, Bloomberg Law Reports

As the Congressional term nears its end, both houses continue to consider legislation that, if enacted, will change substantially important features of the current Patent Act.1 Post-grant review.

(2) Upcoming Events

Workshop on Tensor Decompositions and Applications
James Raynolds will present "An Algebraic Approach to Optimizing Tensor Operations in MATLAB (and other production languages interpreted or compiled)".

Media Contact

Erin S. West Communications and Marketing Manager

p 202.772.8878   f 202.371.2540

email